SWM
IBB icon

Strategic Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Strategic Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-42,660
Closed -$4.31M – 20
2015
Q3 		$4.31M Buy
42,660
+9,843
+30% +$1.18M 7.89% 7
2015
Q2 		$4.04M Sell
32,817
-14,919
-31% -$1.79M 4.67% 10
2015
Q1 		$5.46M Sell
47,736
-51,195
-52% -$5.65M 5.44% 6
2014
Q4 		$10M Buy
98,931
+4,605
+5% +$448K 9.74% 1
2014
Q3 		$8.6M Sell
94,326
-67,779
-42% -$5.95M 8.96% 1
2014
Q2 		$13.9M Buy
162,105
+133,584
+468% +$10.5M 14.23% 2
2014
Q1 		$2.25M Sell
28,521
-56,361
-66% -$4.7M 2.1% 16
2013
Q4 		$6.42M Sell
84,882
-67,437
-44% -$4.78M 6.5% 9
2013
Q3 		$10.6M Sell
152,319
-35,613
-19% -$2.33M 11.69% 1
2013
Q2 		$10.9M Buy
+187,932
New +$10.9M 11.41% 1

Other funds holding IBB

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Strategic Wealth Management's IBB Position: Q4 2015 in Review

Strategic Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q4 2015, closing a stake of 42,660 shares — an estimated $4.31M sold.

Strategic Wealth Management first reported a position in IBB in Q2 2013 and held it in 10 quarters. The position peaked at $13.9M in Q2 2014. 431 funds tracked by Wall St. Rank hold IBB as of Q4 2015.

  • Strategic Wealth Management reported no remaining iShares Biotechnology ETF position as of Q4 2015 after selling out during the quarter.
  • Strategic Wealth Management sold 42,660 iShares Biotechnology ETF shares in Q4 2015, an estimated $4.31M.
  • Strategic Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 10 quarters.
  • Strategic Wealth Management's iShares Biotechnology ETF position peaked at $13.9M in Q2 2014.
  • 431 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2015.

Based on Strategic Wealth Management's 13F filing for Q4 2015, filed 21 Jan 2016.